{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-071891","form_type":"8-K","ticker":"ELOX","cik":"0001035354","company_name":"Eloxx Pharmaceuticals, Inc.","filed_at":"2022-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.408007+00:00","generated_at":"2026-06-25T01:06:14.698508+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Eloxx shareholders elect all nine director nominees, ratify Deloitte, approve say-on-pay","bullets":["50,160,111 shares present (57.88% of outstanding) at June 15, 2022 annual meeting.","All nine director nominees elected; votes for ranged from 21,179,908 to 25,579,083.","Ratification of Deloitte as auditor: 49,488,639 for, 598,786 against.","Advisory vote on executive compensation approved: 24,778,473 for, 1,082,703 against.","Broker non-votes were 24,280,981 on director elections and say-on-pay."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-071891","json":"https://secwatch.observer/filing/0001104659-22-071891.json","markdown":"https://secwatch.observer/filing/0001104659-22-071891.md","text":"https://secwatch.observer/filing/0001104659-22-071891.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035354/000110465922071891/0001104659-22-071891-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035354/000110465922071891/tm2218608d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:06:14.698508+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}